Facebook Twitter LinkedIn Google Plus RSS

DiaVacs Inc. appoints chief medical officer

By

Edgewater-based biotechnology company DiaVacs Inc. announced today the appointment of Dr. Orville Kolterman as chief medical officer. Kolterman will assume responsibility for the company's clinical development and medical affairs.

According to the announcement, the proprietary core technologies DiaVacs employs to create its dendritic cell therapies allow the immune system to be "retrained" to halt autoimmune attacks against the body's own tissues.

Write to the Editorial Department at editorial@njbiz.com

Related Stories

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!